Home » Topics » Disease categories and therapies » Infection

Infection
RSS

SKB's Vectavir introduced in Germany

March 12, 1997

Genome Therapeutics and Versicor collaborate on new antibacterial compounds

March 12, 1997

New antibacterial agents from Daiichi

March 12, 1997

Antibacterial agent isolated by Sanwa Kagaku

March 12, 1997

Sankyo prepares antifungal agents

March 11, 1997

Synsorb sponsors research on carbohydrate synthesis

March 10, 1997

New antifungal agents from Lilly

March 10, 1997

Abelcet receives additional European approval

March 6, 1997

Antisense-based drug highly effective for eradicating RSV

March 6, 1997

Advisory committee to review supplemental NDA for Maxipime

March 4, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 8, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 8, 2024.
Sales balloon for GLP-1 drugs from Novo Nordisk, Eli Lilly
BioWorld
Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide-1 (GLP-1) drugs to treat obesity....
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.